Trial · NCT07524101
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
NCT07524101, Not applicable, Recruiting, Yonsei University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD. Trials, record NCT07524101. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07524101
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
- NCT number
- NCT07524101
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 1,952 participants, estimated
- Lead sponsor
- Yonsei University
- Conditions
- Renal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia, Cardiovascular Diseases
- Interventions
- Moderate-intensity statin and ezetimibe combination therapy, High-intensity statin monotherapy
- First posted
- 2026-04-13
- Last updated
- 2026-06-16
Source ClinicalTrials.gov
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Major adverse cardiovascular events | 3 years | Composite of cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization. |
| Secondary | CKD progression | 3 years | CKD progression: ≥40% decline in eGFR from baseline, confirmed on at least two consecutive measurements during follow-up. |
| Secondary | Cardiovascular death. | 3 years | Death due to cardiovascular causes during follow-up. |
| Secondary | Myocardial infarction. | 3 years | Occurrence of myocardial infarction during follow-up. |
| Secondary | Stroke. | 3 years | Occurrence of stroke during follow-up |
| Secondary | Hospitalization for unstable angina. | 3 years | Hospitalization due to unstable angina during follow-up. |
| Secondary | Coronary revascularization. | 3 years | Any coronary revascularization procedure, including percutaneous coronary intervention or coronary artery bypass graft surgery, during follow-up. |
| Secondary | Composite of cardiovascular death, myocardial infarction, and stroke. | 3 years | First occurrence of cardiovascular death, myocardial infarction, or stroke during follow-up. |
| Secondary | Composite of cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina | 3 years | First occurrence of cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina during follow-up |
| Secondary | Composite of cardiovascular death, myocardial infarction, stroke, and coronary revascularization. | 3 years | First occurrence of cardiovascular death, myocardial infarction, stroke, or coronary revascularization during follow-up. |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07524101
GET https://conductscience.org/api/trials/v1/NCT07524101/registered?page=2